280 related articles for article (PubMed ID: 15482955)
21. Is good housekeeping the key to motor neuron survival?
Talbot K; Davies KE
Cell; 2008 May; 133(4):572-4. PubMed ID: 18485864
[TBL] [Abstract][Full Text] [Related]
22. In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy.
Hahnen E; Eyüpoglu IY; Brichta L; Haastert K; Tränkle C; Siebzehnrübl FA; Riessland M; Hölker I; Claus P; Romstöck J; Buslei R; Wirth B; Blümcke I
J Neurochem; 2006 Jul; 98(1):193-202. PubMed ID: 16805808
[TBL] [Abstract][Full Text] [Related]
23. Histologic and transcriptional assessment of a mild SMA model.
Balabanian S; Gendron NH; MacKenzie AE
Neurol Res; 2007 Jul; 29(5):413-24. PubMed ID: 17535551
[TBL] [Abstract][Full Text] [Related]
24. The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy.
Wan L; Battle DJ; Yong J; Gubitz AK; Kolb SJ; Wang J; Dreyfuss G
Mol Cell Biol; 2005 Jul; 25(13):5543-51. PubMed ID: 15964810
[TBL] [Abstract][Full Text] [Related]
25. [Molecular basis of spinal muscular atrophy: th SMN gene].
Tizzano E; Baiget M
Neurologia; 2000 Nov; 15(9):393-400. PubMed ID: 11195146
[TBL] [Abstract][Full Text] [Related]
26. A clinical, magnetic resonance imaging, and survival motor neuron gene deletion study of Hirayama disease.
Misra UK; Kalita J; Mishra VN; Kesari A; Mittal B
Arch Neurol; 2005 Jan; 62(1):120-3. PubMed ID: 15642858
[TBL] [Abstract][Full Text] [Related]
27. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector.
Baughan T; Shababi M; Coady TH; Dickson AM; Tullis GE; Lorson CL
Mol Ther; 2006 Jul; 14(1):54-62. PubMed ID: 16580882
[TBL] [Abstract][Full Text] [Related]
28. In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate.
Brichta L; Holker I; Haug K; Klockgether T; Wirth B
Ann Neurol; 2006 Jun; 59(6):970-5. PubMed ID: 16607616
[TBL] [Abstract][Full Text] [Related]
29. Stat5 constitutive activation rescues defects in spinal muscular atrophy.
Ting CH; Lin CW; Wen SL; Hsieh-Li HM; Li H
Hum Mol Genet; 2007 Mar; 16(5):499-514. PubMed ID: 17220171
[TBL] [Abstract][Full Text] [Related]
30. Smn deficiency causes neuritogenesis and neurogenesis defects in the retinal neurons of a mouse model of spinal muscular atrophy.
Liu H; Beauvais A; Baker AN; Tsilfidis C; Kothary R
Dev Neurobiol; 2011 Feb; 71(2):153-69. PubMed ID: 20862739
[TBL] [Abstract][Full Text] [Related]
31. Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?
Rossoll W; Kröning AK; Ohndorf UM; Steegborn C; Jablonka S; Sendtner M
Hum Mol Genet; 2002 Jan; 11(1):93-105. PubMed ID: 11773003
[TBL] [Abstract][Full Text] [Related]
32. Co-regulation of survival of motor neuron and Bcl-xL expression: implications for neuroprotection in spinal muscular atrophy.
Anderton RS; Price LL; Turner BJ; Meloni BP; Mitrpant C; Mastaglia FL; Goh C; Wilton SD; Boulos S
Neuroscience; 2012 Sep; 220():228-36. PubMed ID: 22732506
[TBL] [Abstract][Full Text] [Related]
33. Survival of motor neuron gene downregulation by RNAi: towards a cell culture model of spinal muscular atrophy.
Trülzsch B; Davies K; Wood M
Brain Res Mol Brain Res; 2004 Jan; 120(2):145-50. PubMed ID: 14741404
[TBL] [Abstract][Full Text] [Related]
34. Other forms of survival motor neuron protein and spinal muscular atrophy: an opinion.
Burghes HM
Neuromuscul Disord; 2008 Jan; 18(1):82-3. PubMed ID: 18365339
[No Abstract] [Full Text] [Related]
35. Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms.
Nizzardo M; Nardini M; Ronchi D; Salani S; Donadoni C; Fortunato F; Colciago G; Falcone M; Simone C; Riboldi G; Govoni A; Bresolin N; Comi GP; Corti S
Exp Neurol; 2011 Jun; 229(2):214-25. PubMed ID: 21295027
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy.
Murray LM; Beauvais A; Gibeault S; Courtney NL; Kothary R
Acta Neuropathol Commun; 2015 Sep; 3():55. PubMed ID: 26374403
[TBL] [Abstract][Full Text] [Related]
37. Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III.
Jablonka S; Schrank B; Kralewski M; Rossoll W; Sendtner M
Hum Mol Genet; 2000 Feb; 9(3):341-6. PubMed ID: 10655542
[TBL] [Abstract][Full Text] [Related]
38. On the possible role of muscle in the pathogenesis of spinal muscular atrophy.
Guettier-Sigrist S; Coupin G; Braun S; Rogovitz D; Courdier I; Warter JM; Poindron P
Fundam Clin Pharmacol; 2001 Feb; 15(1):31-40. PubMed ID: 11468011
[TBL] [Abstract][Full Text] [Related]
39. Co-regulation of survival of motor neuron (SMN) protein and its interactor SIP1 during development and in spinal muscular atrophy.
Jablonka S; Bandilla M; Wiese S; Bühler D; Wirth B; Sendtner M; Fischer U
Hum Mol Genet; 2001 Mar; 10(5):497-505. PubMed ID: 11181573
[TBL] [Abstract][Full Text] [Related]
40. The survival motor neuron protein in spinal muscular atrophy.
Coovert DD; Le TT; McAndrew PE; Strasswimmer J; Crawford TO; Mendell JR; Coulson SE; Androphy EJ; Prior TW; Burghes AH
Hum Mol Genet; 1997 Aug; 6(8):1205-14. PubMed ID: 9259265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
